Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Chen Tian(Tianjin Medical University Cancer Institute and Hospital), Jing Zhang(Sichuan University)
Cited by 112
Related Papers
Phosphorylated α-Synuclein in Parkinson’s Disease
|Science Translational Medicine|2012|277
Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?
|Acta Neuropathologica Communications|2017|275
Phosphorylated alpha-Synuclein in Parkinson's Disease
|Science Translational Medicine|2012|77
Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models
|iScience|2021|32
Gasotransmitter Research Advances in Respiratory Diseases
|Antioxidants and Redox Signaling|2023|14